Five years from now, Moderna could be synonymous with personalised cancer vaccines, not Covid-19. Chief executive Stéphane Bancel talks with Scottish Mortgage Manager Tom Slater about what can be achieved through programmable drug development. “There are huge areas of unmet clinical need that cause untold human suffering, that [Moderna’s] technology will be able to address.” […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated